Breast Cancer Foundation NZ - Scalp Cooling Equipment

The scalp cooling equipment is available for patients receiving chemotherapy to help reduce the degree of hair loss associated with chemotherapy.

Collection of Outcome

Primary Outcome:

Measure of Effectiveness 1 month Post Treatment

Using Common Terminology Criteria for Adverse Events (CTCAE) v 4.03 where Grade 1 Alopecia will be defined as success to treatment

Secondary Outcome:

Tolerability: Defined as ability to complete all planned chemotherapy cycles using Paxman Scalp Cooling

Adverse Event Data

Adverse event data will be collected in particular the rates and severity of headache, dizziness, pruritis, scalp skin reaction. Potential events leading to fault in the device for e.g. scalp machine malfunction will also be recorded.

For more information please contact your oncologist or speak to your oncology nurse.